Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

Suchergebnisse filtern
Datenmodelle auswählen

Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

19 Suchergebnisse.

Eligibility Lymphoma NCT02072655

- 05.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization; ODM derived from: https://clinicaltrials.gov/show/NCT02072655

Eligibility Tumors NCT01403779

- 23.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01403779

Eligibility Eversion in Dermatologic Surgery NCT01770002

- 22.09.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?; ODM derived from: https://clinicaltrials.gov/show/NCT01770002 Sponsor: University of California, Davis Information provided by (Responsible Party): University of California, Davis Principal Investigator: Daniel Eisen, M.D. University of California, Davis

Eligibility Breast Cancer NCT02061527

- 06.02.19 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT02061527

Eligibility Breast Cancer NCT01736605

- 17.09.19 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction; ODM derived from: https://clinicaltrials.gov/show/NCT01736605

Eligibility Breast Carcinoma NCT01199354

- 08.12.18 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC); ODM derived from: https://clinicaltrials.gov/show/NCT01199354

Eligibility Breast Cancer NCT01917578

- 20.09.21 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction; ODM derived from: https://clinicaltrials.gov/show/NCT01917578

Eligibility Basal Cell Carcinoma NCT02059252

- 09.10.18 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold; ODM derived from: https://clinicaltrials.gov/show/NCT02059252 Collaborating Parties: Welsh Centre for Burns and Plastic Surgery, Swansea, UK Queen Victoria Hospital NHS Foundation Trust

Eligibility Breast Neoplasms NCT00187343

- 18.07.16 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT); ODM derived from: https://clinicaltrials.gov/show/NCT00187343

Eligibility Knee Pain Chronic NCT01345123

- 14.06.20 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Supporting Decision Making for Musculoskeletal Preference-Sensitive Care; ODM derived from: https://clinicaltrials.gov/show/NCT01345123

Evaluation of Naproxen Sodium and Sumatriptan in Adolescent Subjects With Migraine and Healthy Adult Subjects NCT00989625 - Screen - Eligibility Question

- 08.08.19 - 1 Formular, 6 Itemgruppen, 6 Datenelemente, 1 Sprache

Itemgruppen: Date of visit/assessment, Eligibility Question, Inclusion Criteria, Exclusion Criteria, Inclusion Criteria ADOLESCENTS ONLY, Exclusion Criteria ADOLESCENTS ONLY

Study ID: 108504 Clinical Study ID: 108504 Study Title: An Open Label, Single Dose, Randomised, Parallel Group Pharmacokinetic Study to Evaluate a Combination Product Containing Naproxen Sodium and Sumatriptan in Adolescent Subjects With Migraine and Healthy Adult Subjects Administered at Three Doses. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00989625 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: This is a pharmacokinetic study (Treximet) Trade Name: Naproxen Sodium and Sumatriptan Study Indication: Migraine Disorders

Eligibility Pain NCT01119885

- 15.08.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache

Itemgruppen: Inclusion Criteria, Exclusion Criteria

Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip; ODM derived from: https://clinicaltrials.gov/show/NCT01119885

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.